Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Effects of Tirzepatide on Metabolic Parameters in Patients with Psoriasis and Obesity: 24-Week Real-World Study
Dermatology and therapy, 2026
Tirzepatide in type 1 diabetes: beyond mere weight loss
Expert review of clinical pharmacology, 2026
Risk Factors for Hypoglycemia in Type 2 Diabetes Mellitus Patients Using Once-Weekly Semaglutide: A Matched Case-Control Study
Therapeutics and clinical risk management, 2026;22:610579
CGM-derived postprandial glucose with IcoSema versus other insulin regimens: a post hoc analysis of COMBINE 1 and 3
EClinicalMedicine, 2026;96:103985
LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease
Immunity, inflammation and disease;14(5):e70451
Tirzepatide for weight and behavior management in a patient with Smith-Magenis syndrome
JCEM case reports, 2026;4(7):luag152
Comparative Positioning of Orforglipron Among Selected GLP-1 Receptor Agonist Benchmarks: A Narrative Review
Cureus, 2026;18(6):e110178
Ocular disorders during treatment with GLP-1 receptor agonists: a systematic review and meta-analysis of observational studies
Frontiers in pharmacology, 2026;17:1808359
Longitudinal 18F-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET) Findings in Korsakoff Syndrome After Rapid Weight Loss During Tirzepatide Therapy: A Case Report
Cureus, 2026;18(6):e110101
A systematic review of semaglutide-associated kidney injury case reports
Frontiers in medicine, 2026;13:1793349
Glucagon-like peptide-1 receptor agonists as a metabolic optimization strategy in surgical prehabilitation: a translational perspective
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2026
Glucagonlike Peptide-1 (GLP-1) Receptor Agonists for Cardiometabolic Risk in Severe Mental Illness: A Narrative Review
Cureus, 2026;18(6):e110038
GLP-1RA- and Incretin-Based Therapies Within Lifestyle Interventions for Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis
Nutrients, 2026;18(11)
Prescribing of GLP-1 and GIP/GLP-1 Receptor Agonists and Other Glucose-Lowering Drugs Requiring Special Caution in Elderly Japanese People With Type 2 Diabetes: A Preliminary Report
Journal of clinical medicine research, 2026;18(5):292-300
Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions-A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
Pharmaceuticals (Basel, Switzerland), 2026;19(6)
Impact of Semaglutide on Hippocampal Injury in a Streptozotocin-Induced Model of Alzheimer’s Disease
Biomedicines, 2026;14(6)
Incretin-Based Therapies in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF): A Systematic Review of Emerging Cardiometabolic Disease Modification Beyond Glycemic Control
Cureus, 2026;18(5):e109953
BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase
International journal of molecular sciences, 2026;27(11)
Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach
Pharmaceuticals (Basel, Switzerland), 2026;19(6)
Prolonged Dysesthesia After Massive Accidental Semaglutide Overdose: A Case Report
Journal of the American College of Emergency Physicians open, 2026;7(4):100427